Remove CMS Remove Outpatient Remove Reimbursement
article thumbnail

BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study

DAIC

CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage.

CMS 111
article thumbnail

HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT

DAIC

In the hospital setting, CMS increased payment for the FFRCT service by ~7% for 2024. The new code can be used for hospital outpatient, physician offices, or imaging centers. Better reimbursement for hospitals leads to improved accessibility to this technology, which is a win for everyone involved, most notably patients.”

article thumbnail

Us2.ai’s Echo Strain Validation

CardiacWire

with HFpEF) That last part is notable from an echo AI adoption perspective, given that CMS recently approved an outpatient reimbursement code for AI-based HFpEF detection ($285 per use) It could also prove to be notable for Us2.ai, The post Us2.ai’s ai’s Echo Strain Validation appeared first on Cardiac Wire.